《美国股市》道指升55点或0.2% 三大股指续破顶
美股上升,美股三大指数创收市新高。美国总统特朗普称中美首阶段贸易协议谈判已达最後阶段,迪士尼串流视像订阅情况理想,均支持大市。道指尾段曾升79点见28,146点历史新高。
道琼斯工业平均指数升55.21点或0.2%,收报28,121.68点。
标准普尔500指数升6.88点或0.2%,收报3,140.52点。
纳斯达克指数升15.44点或0.2%,收报8,647.93点。
默沙东药厂及宝洁各升1.9%及1.5%,为升幅最大道指成分股,迪士尼及可口可乐各升1.3%。连锁药房Walgreens跌1.7%,为跌幅最大道指成分股。百思买季绩胜预期,股价升9.9%。惠普企业季度收入逊预期,股价跌8.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.